Gisela Paulsen - Oct 4, 2021 Form 3 Insider Report for Oncocyte Corp (OCX)

Role
Chief Operating Officer
Signature
/s/ Gisela Paulsen
Stock symbol
OCX
Transactions as of
Oct 4, 2021
Transactions value $
$0
Form type
3
Date filed
10/14/2021, 04:05 PM
Next filing
Mar 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCX Option to Purchase Common Stock Oct 4, 2021 Common Stock 375K $3.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options will become exercisable after one year of continuous employment from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continued employment on the applicable vesting date.